Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline variation of Ribonuclease H2 genes in ovarian cancer patients.
Polaczek R, Schürmann P, Speith LM, Geffers R, Dürst M, Hillemanns P, Park-Simon TW, Liebrich C, Dörk T. Polaczek R, et al. Among authors: schurmann p. J Ovarian Res. 2020 Dec 22;13(1):146. doi: 10.1186/s13048-020-00753-1. J Ovarian Res. 2020. PMID: 33353557 Free PMC article.
Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N, Feshchenko S, Schürmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, Dörk T. Bogdanova N, et al. Among authors: schurmann p. Int J Cancer. 2008 Feb 15;122(4):802-6. doi: 10.1002/ijc.23168. Int J Cancer. 2008. PMID: 17957789
NBS1 variant I171V and breast cancer risk.
Bogdanova N, Schürmann P, Waltes R, Feshchenko S, Zalutsky IV, Bremer M, Dörk T. Bogdanova N, et al. Among authors: schurmann p. Breast Cancer Res Treat. 2008 Nov;112(1):75-9. doi: 10.1007/s10549-007-9820-4. Epub 2007 Nov 30. Breast Cancer Res Treat. 2008. PMID: 18049891
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A, Coinac I, Bogdanova N, Dubrowinskaja N, Turmanov N, Haubold S, Schürmann P, Imkamp F, von Klot C, Merseburger AS, Machtens S, Bremer M, Hillemanns P, Kuczyk MA, Karstens JH, Serth J, Dörk T. Meyer A, et al. Among authors: schurmann p. Urol Oncol. 2013 Jan;31(1):74-81. doi: 10.1016/j.urolonc.2010.09.011. Epub 2011 Mar 10. Urol Oncol. 2013. PMID: 21396839
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.
Jamshidi M, Schmidt MK, Dörk T, Garcia-Closas M, Heikkinen T, Cornelissen S, van den Broek AJ, Schürmann P, Meyer A, Park-Simon TW, Figueroa J, Sherman M, Lissowska J, Keong GT, Irwanto A, Laakso M, Hautaniemi S, Aittomäki K, Blomqvist C, Liu J, Nevanlinna H. Jamshidi M, et al. Among authors: schurmann p. Int J Cancer. 2013 May 1;132(9):2044-55. doi: 10.1002/ijc.27884. Epub 2012 Oct 25. Int J Cancer. 2013. PMID: 23034890 Free PMC article.
CYP2B6*6 is associated with increased breast cancer risk.
Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Dörk T, Schürmann P, Bogdanova N, Park-Simon TW, Couch FJ, Olson JE, Fasching PA, Beckmann MW, Häberle L, Ekici A, Hall P, Czene K, Liu J, Li J, Baisch C, Hamann U, Ko YD, Brauch H. Justenhoven C, et al. Among authors: schurmann p. Int J Cancer. 2014 Jan 15;134(2):426-30. doi: 10.1002/ijc.28356. Epub 2013 Jul 30. Int J Cancer. 2014. PMID: 23824676 Free PMC article.
Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.
Kohlhase S, Bogdanova NV, Schürmann P, Bermisheva M, Khusnutdinova E, Antonenkova N, Park-Simon TW, Hillemanns P, Meyer A, Christiansen H, Schindler D, Dörk T. Kohlhase S, et al. Among authors: schurmann p. PLoS One. 2014 Jan 21;9(1):e85334. doi: 10.1371/journal.pone.0085334. eCollection 2014. PLoS One. 2014. PMID: 24465539 Free PMC article.
Prediction of breast cancer risk based on profiling with common genetic variants.
Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnu… See abstract for full author list ➔ Mavaddat N, et al. Among authors: schurmann p. J Natl Cancer Inst. 2015 Apr 8;107(5):djv036. doi: 10.1093/jnci/djv036. Print 2015 May. J Natl Cancer Inst. 2015. PMID: 25855707 Free PMC article.
189 results